BioXcel Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
BioXcel Therapeutics, Inc. (BTAI) reported Basic Shares Outstanding (Weighted Average) of 30.30 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- BioXcel Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 30.30M shares, a 286.33% increase year-over-year.
- BioXcel Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 23.57M shares, a 387.61% increase year-over-year.
- BioXcel Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 21.86M shares, a 618.47% increase year-over-year.
- BioXcel Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 14.20M shares, a 435.90% increase year-over-year.
- BioXcel Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 12.21M shares, a 381.58% increase from fiscal 2024.
- BioXcel Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 2.54M shares, a 39.21% increase from fiscal 2023.
- BioXcel Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 1.82M shares, a 93.50% decline from fiscal 2022.
- BioXcel Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 28.02M shares, a 6.23% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 30.30M shares 10-Q · filed 2026-08-13 | 26.95M shares 10-Q · filed 2026-08-13 | 25.24M shares derived: average of 3 quarters · filed 2026-08-13 | 22.48M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | 23.57M shares 10-Q · filed 2026-05-15 | 22.71M shares derived: average of 2 quarters · filed 2026-05-15 | 19.87M shares derived: average of 3 quarters · filed 2026-05-15 | 16.87M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | 21.86M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | 18.03M shares derived: average of 2 quarters · filed 2026-03-27 | 14.63M shares derived: average of 3 quarters · filed 2026-08-13 | 12.21M shares 10-K · filed 2026-03-27 | ||||
| 2025-09-30 | 14.20M shares 10-Q · filed 2025-11-12 | 11.02M shares derived: average of 2 quarters · filed 2026-08-13 | 8.99M shares 10-Q · filed 2025-11-12 | 7.48M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | 7.84M shares 10-Q · filed 2026-08-13 | 6.35M shares 10-Q · filed 2026-08-13 | 5.24M shares derived: average of 3 quarters · filed 2026-08-13 | 4.59M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | 4.83M shares 10-Q · filed 2026-05-15 | 3.94M shares derived: average of 2 quarters · filed 2026-05-15 | 3.51M shares derived: average of 3 quarters · filed 2026-05-15 | 3.26M shares derived: average of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | 3.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | 2.85M shares derived: average of 2 quarters · filed 2026-03-27 | 2.74M shares derived: average of 3 quarters · filed 2026-03-27 | 2.54M shares 10-K · filed 2026-03-27 | ||||
| 2024-09-30 | 2.65M shares 10-Q · filed 2025-11-12 | 42.39M shares 10-Q · filed 2024-11-14 | 2.58M shares derived: average of 2 quarters · filed 2025-11-12 | 2.37M shares 10-Q · filed 2025-11-12 | 37.85M shares 10-Q · filed 2024-11-14 | -18.18M shares derived: average of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | 2.52M shares 10-Q · filed 2025-08-12 | 40.25M shares 10-Q · filed 2024-08-06 | 2.22M shares 10-Q · filed 2025-08-12 | 35.56M shares 10-Q · filed 2024-08-06 | -25.12M shares derived: average of 3 quarters · filed 2025-08-12 | -11.52M shares derived: average of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | 1.93M shares 10-Q · filed 2025-05-12 | 30.87M shares 10-Q · filed 2024-05-09 | -38.93M shares derived: average of 2 quarters · filed 2025-05-12 | -16.20M shares derived: average of 3 quarters · filed 2025-05-12 | -4.85M shares derived: average of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | -79.79M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -25.26M shares derived: average of 2 quarters · filed 2025-03-28 | -7.11M shares derived: average of 3 quarters · filed 2025-03-28 | 1.82M shares 10-K · filed 2025-03-28 | 29.13M shares 10-K · filed 2024-03-22 | |||
| 2023-09-30 | 29.27M shares 10-Q · filed 2024-11-14 | 29.23M shares derived: average of 2 quarters · filed 2024-11-14 | 29.03M shares 10-Q · filed 2024-11-14 | 28.79M shares derived: average of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | 29.19M shares 10-Q · filed 2024-08-06 | 28.90M shares 10-Q · filed 2024-08-06 | 28.62M shares derived: average of 3 quarters · filed 2024-08-06 | 28.47M shares derived: average of 4 quarters · filed 2024-08-06 | ||||
| 2023-03-31 | 28.62M shares 10-Q · filed 2024-05-09 | 28.34M shares derived: average of 2 quarters · filed 2024-05-09 | 28.24M shares derived: average of 3 quarters · filed 2024-05-09 | 28.17M shares derived: average of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | 28.07M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | 28.05M shares derived: average of 2 quarters · filed 2024-03-22 | 28.03M shares derived: average of 3 quarters · filed 2024-03-22 | 28.02M shares 10-K · filed 2024-03-22 | ||||
| 2022-09-30 | 28.02M shares 10-Q · filed 2023-11-14 | 28.01M shares derived: average of 2 quarters · filed 2023-11-14 | 28.00M shares 10-Q · filed 2023-11-14 | 28.00M shares derived: average of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | 27.99M shares 10-Q · filed 2023-08-14 | 27.98M shares 10-Q · filed 2023-08-14 | 27.99M shares derived: average of 3 quarters · filed 2023-08-14 | 27.98M shares derived: average of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | 27.98M shares 10-Q · filed 2023-05-09 | 27.99M shares derived: average of 2 quarters · filed 2023-05-09 | 27.98M shares derived: average of 3 quarters · filed 2023-05-09 | 27.23M shares derived: average of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | 28.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | 27.98M shares derived: average of 2 quarters · filed 2023-03-16 | 26.98M shares derived: average of 3 quarters · filed 2023-03-16 | 26.37M shares 10-K · filed 2023-03-16 | ||||
| 2021-09-30 | 27.97M shares 10-Q · filed 2022-11-14 | 26.47M shares derived: average of 2 quarters · filed 2022-11-14 | 25.83M shares 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | 24.96M shares 10-Q · filed 2022-08-11 | 24.74M shares 10-Q · filed 2022-08-11 | ||||||
| 2021-03-31 | 24.52M shares 10-Q · filed 2022-05-09 | |||||||
| 2020-12-31 | 21.68M shares 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |